Mitochondria protecting agents for treating mitochondria associated diseases
    7.
    发明授权
    Mitochondria protecting agents for treating mitochondria associated diseases 失效
    线粒体保护剂用于治疗线粒体相关疾病

    公开(公告)号:US06498191B2

    公开(公告)日:2002-12-24

    申请号:US09733271

    申请日:2000-12-07

    IPC分类号: A61K31225

    摘要: The present invention relates generally to mitochondria protecting agents for treating diseases in which mitochondrial dysfunction leads to tissue degeneration and, more specifically, to compounds, compositions and methods related to the same. The methods of this invention involve administration of a pharmaceutically effective amount of a mitochondria protecting agent to a warm-blooded animal in need thereof, and composition of this invention contain a mitochondria protecting agent in combination with a pharmaceutically acceptable carrier or diluent. Mitochondrial associated diseases which may be treated by the present invention include (but are not limited to) Alzheimer's Disease, diabetes mellitus, Parkinson's Disease, neuronal and cardiac ischemia, Huntington's disease and stroke.

    摘要翻译: 本发明一般涉及用于治疗线粒体功能障碍导致组织变性的线粒体保护剂,更具体地涉及与其相关的化合物,组合物和方法。 本发明的方法涉及向有需要的温血动物施用药学有效量的线粒体保护剂,本发明的组合物含有与药学上可接受的载体或稀释剂组合的线粒体保护剂。 可以通过本发明治疗的线粒体相关疾病包括(但不限于)阿尔茨海默氏病,糖尿病,帕金森病,神经元和心脏缺血,亨廷顿病和中风。